These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10655513)

  • 1. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.
    Bai C; Connolly B; Metzker ML; Hilliard CA; Liu X; Sandig V; Soderman A; Galloway SM; Liu Q; Austin CP; Caskey CT
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1230-5. PubMed ID: 10655513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer.
    Mild G; Bachmann F; Boulay JL; Glatz K; Laffer U; Lowy A; Metzger U; Reuter J; Terracciano L; Herrmann R; Rochlitz C
    Int J Cancer; 2002 Nov; 102(3):254-7. PubMed ID: 12397645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
    Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
    Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
    Fujita Y; Sakakura C; Shimomura K; Nakanishi M; Yasuoka R; Aragane H; Hagiwara A; Abe T; Inazawa J; Yamagishi H
    Hepatogastroenterology; 2003; 50(54):1857-63. PubMed ID: 14696419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
    Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
    Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human TDE gene homologue: localization to 20q13.1-13.3 and variable expression in human tumor cell lines and tissue.
    Bossolasco M; Lebel M; Lemieux N; Mes-Masson AM
    Mol Carcinog; 1999 Nov; 26(3):189-200. PubMed ID: 10559794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
    Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
    Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients.
    Wu Y; Han B; Sheng H; Lin M; Moore PA; Zhang J; Wu J
    Int J Cancer; 2003 Jul; 105(5):724-32. PubMed ID: 12740925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
    Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
    Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
    Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
    J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
    Lin L; Aggarwal S; Glover TW; Orringer MB; Hanash S; Beer DG
    Cancer Res; 2000 Mar; 60(5):1341-7. PubMed ID: 10728696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.